MedTrace Logo

Efficacy of Pain Neuroscience Education and Pre-anesthetic Assessment in Reducing Levels of Anxiety, Stress and Pain in Patients Undergoing Elective Total Abdominal Hysterectomy (ENAH Study)

NCT05435508 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2025-12-30

No results posted yet for this study

Summary

Through this quantitative, multivariate factorial experimental parallel randomized clinical trial, the investigators analyzed the effectiveness of pre-anesthetic assessment and pain neuroscience education in reducing anxiety, stress, and pain levels in patients undergoing elective total abdominal hysterectomy.

Conditions

  • Pain, Chronic
  • Pain, Postoperative
  • Anesthesia
  • Surgery
  • Anxiety
  • Stress

Interventions

OTHER

Pain Neuroscience Education

One face-to-face Pain Neuroscience Education (PNE) session was delivered by a professional certified in PNE, with a duration of approximately 35 minutes. The session addressed the neurobiology and neurophysiology of pain, central sensitization, cortical representation of body regions, pain-related changes in body perception, and psychosocial dimensions of pain. Participants also received standard pre-anesthetic assessment, identical to the usual care group.

OTHER

Usual care

Usual care consisted of standard pre-anesthetic assessment and routine perioperative management, including analgesic medication administered before, during, and after hysterectomy, according to institutional protocols and the clinical judgment of the attending physician.

Sponsors & Collaborators

  • Hospital Univeristario Benemerita Universidad Autonoma de Puebla

    collaborator OTHER

  • Instituto Neurociencia Del Dolor

    lead OTHER

Principal Investigators

  • Johana Milena Mejía-Mejía, MD · Hospital Universitario de Puebla BUAP

  • Leidy Tatiana Ordoñez-Mora, MsC · Universidad Santiago de Cali, Cali, Colombia.

  • Michelle Dassaaejv Macias Amezcua, MD · Hospital Universitario de Puebla BUAP

  • Pedro Javier López-Perez, PhD · Universidad de la Costa, Barranquilla, Colombia

  • Marco Antonio Morales-Osorio, PhD · Universidad Arturo Prat, Iquique, Chile.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-02-28
Completion
2025-03-15

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05435508 on ClinicalTrials.gov